Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Non Operating Investment Income: 2021-2022

Historic Non Operating Investment Income for Immuneering (IMRX) over the last 1 years, with Dec 2022 value amounting to $112,353.

  • Immuneering's Non Operating Investment Income rose 353.86% to $112,353 in Q4 2022 from the same period last year, while for Dec 2022 it was $18,889, marking a year-over-year change of. This contributed to the annual value of $18,889 for FY2022, which is 138.54% up from last year.
  • Latest data reveals that Immuneering reported Non Operating Investment Income of $112,353 as of Q4 2022, which was up 187.44% from $39,088 recorded in Q3 2022.
  • In the past 5 years, Immuneering's Non Operating Investment Income registered a high of $112,353 during Q4 2022, and its lowest value of -$118,386 during Q1 2022.
  • Moreover, its 2-year median value for Non Operating Investment Income was -$9,458 (2021), whereas its average is -$5,020.
  • Data for Immuneering's Non Operating Investment Income shows a peak YoY spiked of 922.73% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Immuneering's Non Operating Investment Income stood at -$44,258 in 2021, then surged by 353.86% to $112,353 in 2022.
  • Its last three reported values are $112,353 in Q4 2022, $39,088 for Q3 2022, and -$14,166 during Q2 2022.